Quadrant Capital Group’s Spyre Therapeutics SYRE Stock Holding History

Quadrant Capital Group’s Portfolio SYRE Stock Details SYRE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.37K	Buy
2022 Q1	–	Sell
2021 Q4	$5K	Hold
2021 Q3	$9K	Hold
2021 Q2	$8K	Hold
2021 Q1	$9K	Hold
2020 Q4	$9K	Hold
2020 Q3	$8K	Hold
2020 Q2	$11K	Buy